Press Releases
2008
May
05/06/2008Cepheid to Present at the Robert W. Baird Growth Stock Conference and the Bank of America Healthcare Conference
05/01/2008
Cepheid Reports Record Revenue of $44.8 Million
April
04/07/2008Cepheid Schedules Teleconference and Webcast for First Quarter 2008 Results
04/03/2008
Cepheid Selected as Vendor of Choice by Connecticut Hospital Association Shared Services Program for Molecular MRSA Surveillance Testing
March
03/12/2008Cepheid Comments on Study Regarding MRSA Surveillance Reported in the Journal of the American Medical Association
03/10/2008
Cepheid to Present at Cowen and Company's 28th Annual Healthcare Conference
February
02/28/2008Cepheid Reports Fourth Quarter and Full Year 2007 Results
02/25/2008
Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
02/11/2008
Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
02/06/2008
Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
January
01/29/2008Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
01/07/2008
Cepheid Begins Shipment of Next Generation GeneXpert(R) Molecular Diagnostic Systems
01/03/2008
Cepheid to Present at the Needham Tenth Annual Growth Stock Conference
2007
December
12/06/2007Cepheid to Present at the RBC Capital Markets 2007 Healthcare Conference
12/04/2007
Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
November
11/29/2007Cepheid and Broadlane Sign Group Purchasing Contract for GeneXpert(R) Systems and Xpert(TM) Molecular Diagnostic Tests, Including Xpert MRSA
11/20/2007
Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
11/01/2007
Cepheid Reports Third Quarter 2007 Results
October
10/23/2007Cepheid Schedules Teleconference and Webcast for Third Quarter 2007 Results
September
09/26/2007Cepheid to Present at William Blair Small-Cap Growth Stock Conference
09/24/2007
Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
09/21/2007
Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
09/19/2007
Cepheid Awarded Federal Supply Service Contracts to Provide Veterans Hospitals With Diagnostic Tests and Instruments for MRSA Surveillance
09/17/2007
Cepheid to Present at UBS Global Life Sciences Conference
09/12/2007
Cepheid Announces New Scientific Advisory Board
09/11/2007
Cepheid to Present at ThinkEquity Partners 5th Annual Growth Conference
August
08/30/2007Cepheid to Present at Thomas Weisel Partners Healthcare Conference
08/16/2007
Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
08/07/2007
Cepheid Reports Second Quarter 2007 Results
08/02/2007
Cepheid Schedules Teleconference and Webcast for Second Quarter 2007 Results
July
07/12/2007Cepheid to Host Analyst Reception at the American Association for Clinical Chemistry 2007 Annual Meeting
June
06/13/2007Cepheid to Present at William Blair & Company 27th Annual Growth Stock Conference
May
05/22/2007Cepheid's Xpert(TM) MRSA Test Categorized as 'Moderate Complexity' by FDA
05/03/2007
Cepheid Reports First Quarter 2007 Results
05/03/2007
Houston VA Announces Initiation of MRSA Surveillance Program Using Cepheid's GeneXpert(R) System and Xpert(TM) MRSA Test
April
04/30/2007Cepheid Schedules Teleconference and Webcast for First Quarter 2007 Results
04/25/2007
Cepheid to Present at Robert W. Baird & Co. 2007 Growth Stock Conference
04/23/2007
Cepheid and Instrumentation Laboratory Enter Into Strategic Agreement to Develop and Market Tests for Genetic Risk of Thrombosis
04/18/2007
Cepheid's Xpert(TM) MRSA Test for Methicillin-Resistant Staphylococcus Aureus Receives FDA Clearance
04/17/2007
Cepheid Announces Agreement With VWR International to Distribute Industrial Product in the U.S.
04/11/2007
Cepheid's Xpert(TM) EV Test for Enteroviral Meningitis Gains Adoption at Approximately 20 Leading U.S. Medical Centers